196.47
2.76%
-5.57
전일 마감가:
$202.04
열려 있는:
$201.11
하루 거래량:
295.78K
시가총액:
$7.61B
수익:
$1.06B
순이익/손실:
$90.95M
주가수익비율:
190.75
EPS:
1.03
순현금흐름:
$82.12M
1주 성능:
-4.49%
1개월 성능:
-11.97%
6개월 성능:
+2.78%
1년 성능:
-30.85%
Penumbra Inc Stock (PEN) Company Profile
명칭
Penumbra Inc
전화
510-748-3200
주소
1321 Harbor Bay Parkway, Alameda, CA
Penumbra Inc Stock (PEN) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-09-06 | 개시 | Morgan Stanley | Equal-Weight |
2023-07-19 | 개시 | Robert W. Baird | Outperform |
2023-03-29 | 다운그레이드 | Needham | Buy → Hold |
2023-01-30 | 개시 | Piper Sandler | Overweight |
2022-11-04 | 업그레이드 | Citigroup | Neutral → Buy |
2022-10-12 | 개시 | Jefferies | Buy |
2022-10-05 | 다운그레이드 | Citigroup | Buy → Neutral |
2022-09-09 | 업그레이드 | Needham | Hold → Buy |
2022-07-18 | 개시 | RBC Capital Mkts | Outperform |
2022-04-19 | 개시 | Deutsche Bank | Buy |
2022-03-08 | 개시 | Needham | Hold |
2021-09-16 | 개시 | Truist | Buy |
2021-06-04 | 업그레이드 | BTIG Research | Neutral → Buy |
2020-12-16 | 다운그레이드 | BTIG Research | Buy → Neutral |
2020-10-07 | 재개 | Canaccord Genuity | Buy |
2020-09-29 | 개시 | BTIG Research | Buy |
2020-09-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
2020-03-05 | 개시 | Citigroup | Buy |
2019-06-13 | 재확인 | BofA/Merrill | Buy |
2019-05-30 | 업그레이드 | JP Morgan | Neutral → Overweight |
2019-05-21 | 개시 | William Blair | Outperform |
2018-10-29 | 재개 | BofA/Merrill | Buy |
2018-10-08 | 개시 | RBC Capital Mkts | Outperform |
2018-02-21 | 개시 | William Blair | Outperform |
2018-01-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2015-11-30 | 재확인 | Canaccord Genuity | Buy |
2015-10-13 | 개시 | Wells Fargo | Outperform |
모두보기
Penumbra Inc 주식(PEN)의 최신 뉴스
Penumbra's (PEN) New Launch to Enhance Blood Clot Removal
Zacks Investment Research
GMED vs. PEN: Which Stock Is the Better Value Option?
Zacks Investment Research
Here's Why Penumbra (PEN) is a Strong Growth Stock
Zacks Investment Research
Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse'
Benzinga
Here's Why You Should Retain Penumbra (PEN) Stock for Now
Zacks Investment Research
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Zacks Investment Research
Penumbra Inc (PEN) 재무 분석
Penumbra Inc (PEN) 매출 2024
PEN은 2023-12-31 종료 분기에 대해 매출(지난 12개월)이 1.06B 달러로 보고했으며, 전년대비 +24.95% 상승했습니다.
Penumbra Inc (PEN) 순이익 2024
PEN은 2023-12-31 종료 분기에 대해 순이익(지난 12개월)이 90.95M 달러로 보고했으며, 전년대비 +4,643% 증가했습니다.
Penumbra Inc (PEN) 현금흐름 2024
2023-12-31 종료 분기에 PEN은 현금흐름(지난 12개월)으로 82.12M 달러를 기록했으며, 전년 대비 +209.55% 증가했습니다.
Penumbra Inc (PEN) 주당 순이익 2024
PEN이 보고한 2023-12-31 종료 분기의 주당 순이익(지난 12개월)은 2.31달러이며, 전년 대비 +4,083% 성장했습니다.
Penumbra Inc 주식 (PEN) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Roberts Johanna | EVP, Gen. Counsel & Secretary |
Apr 01 '24 |
Sale |
217.07 |
600 |
130,242 |
64,281 |
Kassing Don W. | Director |
Apr 01 '24 |
Sale |
223.18 |
170 |
37,941 |
1,175 |
Elsesser Adam | CEO and President |
Mar 06 '24 |
Option Exercise |
7.75 |
5,000 |
38,750 |
5,000 |
Bose Arani | Director |
Mar 04 '24 |
Sale |
250.20 |
7,500 |
1,876,500 |
164,294 |
Kassing Don W. | Director |
Mar 01 '24 |
Sale |
234.72 |
778 |
182,612 |
1,345 |
Roberts Johanna | EVP, Gen. Counsel & Secretary |
Mar 01 '24 |
Sale |
237.68 |
600 |
142,607 |
62,997 |
Grewal Harpreet | Director |
Jan 03 '24 |
Sale |
240.82 |
170 |
40,939 |
8,980 |
Sarna Surbhi | Director |
Jan 02 '24 |
Sale |
247.68 |
85 |
21,053 |
2,295 |
Roberts Johanna | EVP, Gen. Counsel & Secretary |
Dec 27 '23 |
Option Exercise |
22.04 |
2,450 |
53,998 |
63,597 |
Roberts Johanna | EVP, Gen. Counsel & Secretary |
Dec 01 '23 |
Sale |
226.42 |
600 |
135,851 |
62,251 |
자본화:
|
볼륨(24시간):